Literature DB >> 14871636

Pneumonia in the very old.

Jean-Paul Janssens1, Karl-Heinz Krause.   

Abstract

Pneumonia is a major medical problem in the very old. The increased frequency and severity of pneumonia in the elderly is largely explained by the ageing of organ systems (in particular the respiratory tract, immune system, and digestive tract) and the presence of comorbidities due to age-associated diseases. The most striking characteristic of pneumonia in the very old is its clinical presentation: falls and confusion are frequently encountered, while classic symptoms of pneumonia are often absent. Community-acquired pneumonia (CAP) and nursing-home acquired pneumonia (NHAP) have to be distinguished. Although there are no fundamental differences in pathophysiology and microbiology of the two entities, NHAP tends to be much more severe, because milder cases are not referred to the hospital, and residents of nursing homes often suffer from dementia, multiple comorbidities, and decreased functional status. The immune response decays with age, yet pneumococcal and influenza vaccines have their place for the prevention of pneumonia in the very old. Pneumonia in older individuals without terminal disease has to be distinguished from end-of-life pneumonia. In the latter setting, the attributable mortality of pneumonia is low and antibiotics have little effect on life expectancy and should be used only if they provide the best means to alleviate suffering. In this review, we focus on recent publications relative to CAP and NHAP in the very old, and discuss predisposing factors, microorganisms, diagnostic procedures, specific aspects of treatment, prevention, and ethical issues concerning end-of-life pneumonia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871636     DOI: 10.1016/S1473-3099(04)00931-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  116 in total

Review 1.  Drug therapy optimization at the end of life.

Authors:  Alfonso J Cruz-Jentoft; Benoit Boland; Lourdes Rexach
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Dysregulated inflammation as a risk factor for pneumonia in the elderly.

Authors:  Angela R Boyd; Carlos J Orihuela
Journal:  Aging Dis       Date:  2011-12       Impact factor: 6.745

Review 3.  Can consuming flavonoids restore old microglia to their youthful state?

Authors:  Saebyeol Jang; Rodney W Johnson
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 4.  Pneumococcal vaccine and patients with pulmonary diseases.

Authors:  Mehdi Mirsaeidi; Golnaz Ebrahimi; Mary Beth Allen; Stefano Aliberti
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

Review 5.  Changing needs of community-acquired pneumonia.

Authors:  Julio Alberto Ramirez; Antonio R Anzueto
Journal:  J Antimicrob Chemother       Date:  2011-04       Impact factor: 5.790

6.  Delirium is a predictor of in-hospital mortality in elderly patients with community acquired pneumonia.

Authors:  Filippo Pieralli; Vieri Vannucchi; Antonio Mancini; Maddalena Grazzini; Giulia Paolacci; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2013-09-19       Impact factor: 3.397

Review 7.  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

Authors:  M H Rozenbaum; P Pechlivanoglou; T S van der Werf; J R Lo-Ten-Foe; M J Postma; E Hak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-14       Impact factor: 3.267

8.  Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.

Authors:  Jing Chen; Jessica B Buchanan; Nathan L Sparkman; Jonathan P Godbout; Gregory G Freund; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2007-10-24       Impact factor: 7.217

9.  Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians.

Authors:  Davidson H Hamer; Fernando Sempértegui; Bertha Estrella; Katherine L Tucker; Alicia Rodríguez; Josefina Egas; Gerard E Dallal; Jacob Selhub; Jeffrey K Griffiths; Simin Nikbin Meydani
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

10.  Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.

Authors:  Takaya Maruyama; Osamu Taguchi; Michael S Niederman; John Morser; Hiroyasu Kobayashi; Tetsu Kobayashi; Corina D'Alessandro-Gabazza; Sei Nakayama; Kimiaki Nishikubo; Takashi Noguchi; Yoshiyuki Takei; Esteban C Gabazza
Journal:  BMJ       Date:  2010-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.